Akari Therapeutics is a biotechnology company focused on developing treatments for autoimmune, inflammatory, and oncology-related conditions. The company has operated as a clinical-stage drug developer centered on therapies for rare and serious diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!